Research Areas
In this section, by far, most Axon Ligands™ are categorized as research tools that find their application in cell signaling and oncology. Targeting a multitude of specific enzymes and receptors, they either stimulate or block particular cellular signaling pathways that are implicated in various kinds of cancer. Naturally, all products in this section can also be found by their specific biological targets as listed in the sections of enzymes, receptors, transcription factors, proteins and/or signaling pathways. Besides the comprehensive set of compounds that targe cell signaling and oncology, selections of Axon Ligands™ have also been made for other research area's such as cardiovascular diseases, angiogenisis, epigenetics, stem cell research, among many others.
| Axon ID | Name | Description | From price | |
|---|---|---|---|---|
| 2534 | (+)-Azasetron hydrochloride | 5-HT3 antagonist | €135.00 | |
| 1107 | (+)-MDL 105725 | 5-HT2A antagonist | Inquire | |
| 2535 | (-)-Azasetron hydrochloride | 5-HT3 antagonist | €135.00 | |
| 1108 | (-)-MDL 105725 | 5-HT2A antagonist | Inquire | |
| 1092 | (-)-NPPCC | 5-HT1A agonist | Inquire | |
| 1359 | (-)-WAY 100135 dihydrochloride | 5-HT1A antagonist | €95.00 | |
| 1016 | (R)-(+)-8-Hydroxy-DPAT hydrobromide | 5-HT1A agonist | €105.00 | |
| 1058 | (R)-(+)-8-Methoxy-2-aminotetraline hydrochloride | Building Block; 5-HT1A agonist | Inquire | |
| 1095 | (R)-(-)-LY 426965 dihydrochloride | 5-HT1A antagonist | €115.00 | |
| 1997 | (R)-6-Hydroxybuspirone hydrochloride | 5-HT1A partial agonist | €105.00 | |
| 1017 | (S)-(-)-8-Hydroxy-DPAT hydrobromide | 5-HT1A agonist | €115.00 | |
| 1059 | (S)-(-)-8-methoxy-2-aminotetraline hydrochloride | Building Block; 5-HT1A agonist | Inquire | |
| 1998 | (S)-6-Hydroxybuspirone hydrochloride | 5-HT1A partial agonist | €105.00 | |
| 1341 | (S)-WAY 100135 dihydrochloride | 5-HT1A antagonist | €95.00 | |
| 1093 | (±)-LY 426965 dihydrochloride | 5-HT1A antagonist | €115.00 | |
| 1106 | (±)-MDL 105725 | 5-HT2A antagonist | €210.00 | |
| 2811 | 25CN-NBOH hydrochloride | Selective brain penetrant 5-HT2A receptor agonist | €150.00 | |
| 1575 | 5-HT6 antagonist 29 | Selective brain penetrant 5-HT6 receptor antagonist | €90.00 | |
| 1068 | 6-Chloro-DPAT hydrochloride | Bioactive tetralin derivative | €105.00 | |
| 1996 | 6-Hydroxybuspirone hydrochloride | 5-HT1A partial agonist | €135.00 | |
| 1015 | 8-Hydroxy-DPAT hydrobromide | 5-HT1A agonist | €60.00 | |
| 1057 | 8-Methoxy-2-aminotetralin hydrochloride | Building Block; 5-HT1A agonist | Inquire | |
| 1097 | Alosetron hydrochloride | 5-HT3 antagonist | €85.00 | |
| 1462 | Azaphen | Antidepressant | €105.00 | |
| 1096 | Azasetron hydrochloride | 5-HT3 antagonist | €90.00 | |
| 2353 | Blonanserin | Potent dopamine D2 and serotonin 5-HT2 antagonist | €65.00 | |
| 2335 | Brexpiprazole dihydrochloride | Drug candidate with high affinity for 5-HT1A, 5-HT2A, D2L, α1B, and α2C-adrenergic receptors | €135.00 | |
| 1257 | BTS 54-505 | 5-HT uptake inhibitor | €85.00 | |
| 1995 | Buspirone hydrochloride | 5-HT1A partial agonist | €50.00 | |
| 1206 | CGS 12066B | 5-HT1B agonist | €75.00 | |